gdc

Gastric Cancer

Lonsurf Approved for Metastatic Gastric or Gastroesophageal Junction Cancer
FDA Approvals, News & UpdatesGastric Cancer
In February 2019, the FDA approved Lonsurf for the treatment of patients with metastatic gastric (stomach) cancer or gastroesophageal junction adenocarcinoma. This drug was previously approved only for patients with metastatic colorectal cancer.
Drugs for Gastric/Gastroesophageal Junction Cancer
Gastric Cancer
Here are the drugs and financial support services available to patients receiving treatment for Gastric/Gastroesophageal Junction Cancer.
Drugs for GIST (Gastrointestinal Stromal Tumor)
Gastric Cancer
Here are the drugs and financial support services available to patients receiving treatment for GIST (Gastrointestinal Stromal Tumor).
A Disney Childhood Until Cancer Enters Stage Left
Gastric CancerPatient Stories
Cathy Sherman Freeman’s father, who was Head of Publications at Walt Disney Studios, passed away of gastrointestinal stromal tumor (GIST), the same rare cancer she was diagnosed with several years ago.
Drugs for Gastric/Gastroesophageal Junction Cancer
Gastric Cancer
Here are the financial support services available to patients receiving treatment for Gastric/Gastroesophageal Junction Cancer.
Drugs for GIST (Gastrointestinal Stromal Tumor)
Gastric Cancer
Here are the financial support services available to patients receiving treatment for GIST (Gastrointestinal Stromal Tumor).

Results 1 - 7 of 7

Subscribe to CONQUER: the patient voice® magazine

Receive timely cancer news & updates, patient stories, and more.

Country